Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer.

Prunella L Blinman Andrew James Martin Michael JeffordDavid GoldsteinDavid BoadleMichelle MorrisNiall TebbuttChristine AikenAndrea Harkin Eva SegelovAndrew HaydonTimothy J Iveson Martin R Stockler

Published in: JNCI cancer spectrum (2020)

Preferences varied substantially, and the benefits many required to warrant an extra 3 months of adjuvant chemotherapy were larger than the benefits of an extra 3 months of chemotherapy calculated in the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) meta-analysis.

Keyphrases

systematic review
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
radiation therapy
meta analyses
locally advanced
case control